Benzinga's Top #PreMarket Losers
June 17, 2015 at 08:15 AM EDT
Ocata Therapeutics Inc (NASDAQ: OCAT) shares declined 8.83 percent to $5.68 in pre-market trading after the company priced $30 ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.